-
Pfizer to Exit ViiV Healthcare as GSK and Shionogi Reshape Ownership
26 Jan 2026 00:01 GMT
… exit their HIV-focused joint venture, ViiV Healthcare. The transaction values Pfizer’s exit … dividend as ViiV cancels Pfizer’s shares. GSK originally formed ViiV Healthcare with Pfizer in 2009 …
-
Heather contracted HIV on an overseas holiday. Women like her are more likely to be overlooked by doctors in Australia
09 Feb 2026 15:02 GMT
… predominant association of HIV with gay men – including among healthcare professionals – … Positive Action Community Grant from ViiV Healthcare, a pharmaceutical company specialising in … medicines to treat and prevent HIV/Aids.
Living in regional Victoria …
-
<![CDATA[Shionogi Acquires $2.1 Billion ViiV Healthcare Shareholdings from Pfizer ]]>
21 Jan 2026 02:09 GMT
… deeper and broader interest in HIV and AIDS while also taking a … Shionogi.
GSK, Pfizer and Shionogi Agree on Changes to ViiV Healthcare Shareholding ViiV Healthcare January 20 …
-
<![CDATA[HIV in the Black Community: Shifting from Stigma and Health Inequalities to Communication and Care Initiatives]]>
07 Feb 2026 16:00 GMT
… marks the annual National Black HIV/AIDS Awareness Day. This is … Partnerships at ViiV Healthcare.
Industry’s Role in Building Awareness
ViiV Healthcare has been … /156509
2.National Black HIV/AIDS Awareness Day. February 7 …
-
What will HIV funding look like in 2026?
07 Feb 2026 10:32 GMT
… monthly HIV prevention jab, lenacapavir, from the US government’s Aids … the Global Fund to Fight Aids, TB & Malaria.
By … from UNAids. Remember, World Aids Day data showed that from … think companies like ViiV and Gilead, which develop HIV drugs, shouldn’t …
-
GSK’s oncology and HIV drugs drive 7% sales rise in 2025
04 Feb 2026 19:33 GMT
… £554m in global sales.
GSK’ HIV portfolio was also a key … ) continued to be GSK’s best-selling HIV drug in 2025, … 4 February, the CEO of GSK-owned ViiV Healthcare, Deborah Waterhouse, noted that … opportunity” to GSK’s future presence in the HIV market.
Success …
-
Community innovations help ensure no one is left behind in Australia’s HIV response
03 Feb 2026 21:20 GMT
… communities.
Tasmanian Council on AIDS, Hepatitis and Related Diseases … Nations people living with HIV.
WA AIDS Council Inc to … , CEO Tasmanian Council on AIDS, Hepatitis and Related Diseases, … from ViiV Healthcare is helping us launch a new HIV-specific …
-
GSK and Shionogi agree to replace Pfizer's stake in ViiV Healthcare
21 Jan 2026 07:55 GMT
… in ViiV Healthcare. Pfizer will receive $1.875 billion and GSK will … in GBP).
ViiV Healthcare, the global specialist HIV company, is dedicated … infectious diseases, with HIV being one of our … ongoing HIV research continues to contribute to ViiV’s pipeline …
-
Shionogi expands ViiV Healthcare stake by $2.13bn as Pfizer sells up
20 Jan 2026 19:16 GMT
… virus (HIV) medicines developer in a $2.13bn deal.
ViiV Healthcare, which … on 19 January.
ViiV Healthcare was established by Pfizer and GSK in a bid … (maraviroc).
ViiV Healthcare’s current product portfolio consists of 15 prescription HIV medicines …
-
Pfizer to exit ViiV Healthcare in $1.9 bn deal
20 Jan 2026 13:39 GMT
… on Tuesday that Pfizer will exit their HIV specialist ViiV Healthcare in a deal … majority holding in the global HIV company.
Pfizer in December had warned … . drugmaker's shares.
GSK established ViiV Healthcare with Pfizer in 2009, with Shionogi …
About
© 1995-2026